Anupam Rasayan India (ANURAS) — Offer Document

📢 Key Event
Anupam Rasayan India Limited and PAC making open offer to acquire 26% stake in Bliss GVS Pharma at ₹299 per share

🔮 What's Next
Offer opens 28 July 2026, closes 10 August 2026; Acquirer may revise price before 3rd working day prior to commencement; upward revision requires public announcement and escrow increase

💡 Investor Takeaway
Shareholders can tender shares until 10 August 2026 to sell up to 26% of Bliss GVS Pharma at ₹299 per share, with full consideration payable within 10 working days after closure.

Anupam Rasayan India Limited (ANURAS) announced that it, along with its wholly owned subsidiary Mates Visa Consultancy Private Limited (PAC), is making a cash open offer to acquire up to 2,77,26,848 equity shares of ₹1 each (26% of Bliss GVS Pharma's expanded voting share capital) at ₹299 per share. The offer is made under SEBI SAST Regulations following the execution of a Share Purchase Agreement to acquire 43.11% of Bliss GVS Pharma. The offer size represents 26% of the expanded voting share capital, with total consideration of [amount not verified] assuming full acceptance. The offer opens on 28 July 2026 and closes on 10 August 2026. The Acquirer has placed ₹160 crore in escrow and has adequate financial arrangements including ₹3,038 crore of available resources. The target company's financials show revenue of ₹1,000.64 crore and net income of [amount context mismatch] crore for FY2026. The filing includes detailed risk factors, financial arrangements, procedural guidelines for share tendering, and tax implications for shareholders.

📄 View Original Announcement (PDF)

📊 Stock Analysis — ANURAS ✨ Ask AI About This